The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2016

Filed:

Jul. 16, 2013
Applicant:

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Inventors:

Walter Hübsch, Wuppertal, DE;

Michael Hahn, Langenfeld, DE;

Alexandros Vakalopoulos, Hilden, DE;

Volkhart Min-Jian Li, Velbert, DE;

Frank Wunder, Wuppertal, DE;

Johannes-Peter Stasch, Solingen, DE;

Karl-Heinz Schlemmer, Wuppertal, DE;

Friederike Stoll, Düsseldorf, DE;

Niels Lindner, Wuppertal, DE;

Eva Maria Becker-Pelster, Wuppertal, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); A61K 31/45 (2006.01); A61K 45/06 (2006.01); A61K 31/197 (2006.01); A61K 31/277 (2006.01); A61K 31/4015 (2006.01); A61K 31/415 (2006.01); A61K 31/421 (2006.01); C07C 255/54 (2006.01); C07D 231/12 (2006.01); C07C 229/50 (2006.01); C07D 263/22 (2006.01); C07D 207/27 (2006.01); C07D 211/76 (2006.01); A61K 31/24 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); C07C 227/18 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/45 (2013.01); A61K 9/0019 (2013.01); A61K 9/0095 (2013.01); A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61K 31/197 (2013.01); A61K 31/24 (2013.01); A61K 31/277 (2013.01); A61K 31/4015 (2013.01); A61K 31/415 (2013.01); A61K 31/421 (2013.01); A61K 45/06 (2013.01); C07C 227/18 (2013.01); C07C 229/50 (2013.01); C07C 255/54 (2013.01); C07D 207/27 (2013.01); C07D 211/76 (2013.01); C07D 231/12 (2013.01); C07D 263/22 (2013.01); A61K 9/08 (2013.01); A61K 9/10 (2013.01); C07C 2102/08 (2013.01); C07C 2102/10 (2013.01);
Abstract

The present application relates to novel substituted aminoindane- and aminotetralinecarboxylic acids, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular and cardiopulmonary diseases.


Find Patent Forward Citations

Loading…